+499.5%
MRNA vs ALK
-33.1%
+532.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ALK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +1.5% | -3.8% | -2.4% |
| 7D | +5.5% | -0.7% | +6.1% | +5.6% |
| 30D | +158.7% | -19.2% | +178.0% | +173.9% |
| 3M | +182.1% | -1.5% | +183.7% | +181.3% |
| 6M | +151.8% | -13.1% | +164.9% | +153.2% |
| YTD | +393.6% | -16.4% | +410.0% | +391.5% |
| 1Y | +499.5% | -33.1% | +532.5% | +455.1% |
| All | +499.5% | -33.1% | +532.5% | +455.1% |
Cumulative growth
Daily Returns
Daily percentage return beside ALK.
Daily Out/Under-Performance
Portfolio return minus ALK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ALK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ALK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling